Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana Carolina Arrais Maia"'
Autor:
Fernanda Maria Maria Santos, Jose Flavio Gomes Marin, Marcos Santos Lima, Wellington F Silva, Rodrigo D Velasques, Ana Carolina Arrais Maia, Marcelo Junqueira Atanazio, Lucas Bassolli de Oliveira Alves, Frederico Rafael Moreira, Carlos Alberto Buchpiguel, Valeria Buccheri, Vanderson Rocha
Publikováno v:
Blood. 140:6586-6587
Autor:
Marcelo Junqueira, Atanazio, Fernanda Maria, Santos, Amanda, Duran, Ana Carolina Arrais, Maia, Lucas Bassolli, Alves, Rodrigo Dolphini, Velasques, Vanderson, Rocha, Valeria, Buccheri
Publikováno v:
Reports of Practical Oncology and Radiotherapy. 27:865-862
The role of consolidation mediastinal radiotherapy (RT) for mediastinal bulky disease in advanced-stage classical Hodgkin lymphoma (cHL) is controversial in the positron emission tomography/computed tomography (PET-CT) era.We reviewed the medical cha
Long Term Outcomes of Adult Lymphoblastic Lymphoma Patients Treated with Pediatric Regimen in Brazil
Autor:
Vanderson Rocha, Wellington F Silva, Elvira Deolinda Rodrigues Pereira Velloso, Ana Carolina Arrais Maia, Eduardo Magalhães Rego, Juliana Pereira
Publikováno v:
Blood. 138:4582-4582
Introduction: Lymphoblastic lymphoma (LBL) is a rare and aggressive neoplasm which is more common in children and young adults. The adoption of pediatric inspired regimens for acute lymphoblastic leukemia (ALL) increased response rates and improved o
Autor:
Wellington F Silva, Vergilio A.R. Colturato, Mariana Nassif Kerbauy, Dalila Cysne, Luciana Tucunduva, Iago Colturato, George M. N. Barros, Nelson Hamerschlak, Ana Carolina Arrais Maia, Vanderson Rocha
Publikováno v:
Blood. 138:2926-2926
Introduction: Allogeneic stem-cell transplantation (HSCT) remains a potentially curative approach for acute lymphoblastic leukemia (ALL), especially for high-risk patients and those with relapsed/refractory disease, although its efficacy is offset by
Autor:
Israel Bendit, Maria Gabriella Cordeiro, Cristóvão Luis Pitangueira Mangueira, Wellington Fernandes da Silva, Danielle Lucon, Ana Carolina Arrais Maia, Elvira Drp Velloso, Vanderson Rocha, Eduardo Magalhães Rego, AM Leal, Valeria Buccheri, RK Kishimoto
Publikováno v:
Blood. 132:5288-5288
Introduction Almost all neoplasms have their prognosis determined by cytogenetic and molecular factors, which determines a tailored approach for each case. According to the World Health Organization, every case of Acute Lymphoblastic Leukemia (ALL) m